(UroToday.com) The Société Internationale D’Urologie (SIU) 2021 annual meeting included a hot topics session on PSMA theranostics with a presentation by Dr. Tobias Maurer discussing the role of targeted salvage surgery in biochemical recurrence. Dr. Maurer started by highlighting from the EAU guidelines that salvage lymph node dissection is not a standard treatment, specifically that “high-level evidence for the oncological value of salvage lymph node dissection is still lacking.”